Analyst Michael Yee of Jefferies maintained a Buy rating on Vertex Pharmaceuticals (VRTX – Research Report), retaining the price target of $550.00. Michael Yee’s rating is based on Vertex ...
Vertex Pharmaceuticals (VRTX – Research Report) received a Buy rating and a $480.00 price target from Cantor Fitzgerald analyst Olivia Brayer yesterday. The company’s shares closed yesterday ...
Scientists discovered a moth that appears 3D despite having flat wings. Tiny structures on its wings reflect light that ...
Researchers have been trying to find new ways to produce and replicate the various useful features observed in nature. Fine ...
Vertex just won approval for a drug to treat one of the most common health problems -- pain. The biotech company is offering an option for patients and doctors who don’t want to go for ...
The FDA recently approved Journavx for treating acute pain. This approval is tremendously important for Vertex Pharmaceuticals. The biotech company has also received other good news over the last ...
HOUSTON, January 22, 2025--(BUSINESS WIRE)--Vertex Energy, Inc. ("Vertex" or the "Company"), a leading specialty refiner and marketer of high-quality refined products, together with its affiliates ...
Figure AI, a robotics company working to bring a general-purpose humanoid robot into commercial and residential use, announced Tuesday on X that it is exiting a deal with OpenAI. The Bay Area ...
Scotiabank raised the firm’s price target on Vertex Pharmaceuticals (VRTX) to $450 from $433 and keeps a Sector Perform rating on the shares. The company had a strong Q4, with revenue beating ...
Today, they’ve made good on that promise with the reveal of the first figures in the collection, and you’re seeing them first here at Comicbook! The wave will include MOTU mashup figures of ...
Vertex has doubled down on cell-based therapies for type 1 diabetes (T1D), buying ViaCyte in a $320 million deal that it says will accelerate development of its own candidate VX-880. The deal has ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback